This content is restricted.
Brief
"On March 20, 2025, the Health Canada issued an update regarding Drugs for Rare Diseases – Nova Scotia Agreement. The Governments of Canada and Nova Scotia signed a bilateral agreement to invest over $39 million over three years to improve access to new drugs for rare diseases for Nova Scotia residents and support enhanced access to existing drugs, early diagnosis, and screening."
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
